Gastrin Vaccine Alone and in Combination With an Immune Checkpoint Antibody Inhibits Growth and Metastases of Gastric Cancer

Gastric cancer is a leading cause of cancer-related deaths worldwide. Recently, clinical studies have demonstrated that many of those with advanced gastric cancer are responsive to immune checkpoint antibody therapy, although the median survival even with these new agents is less than 12 months for...

Descripción completa

Detalles Bibliográficos
Autores principales: Smith, Jill P., Cao, Hong, Chen, Wenqiang, Mahmood, Kanwal, Phillips, Teresa, Sutton, Lynda, Cato, Allen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8672297/
https://www.ncbi.nlm.nih.gov/pubmed/34926305
http://dx.doi.org/10.3389/fonc.2021.788875

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8672297/
https://www.ncbi.nlm.nih.gov/pubmed/34926305
http://dx.doi.org/10.3389/fonc.2021.788875

Ejemplares similares